The Cleveland Clinic’s Lerner Research Institute has secured $13.6 million worth of National Institute of Health grants over the past months evidencing tremendous progress with research pursuits at the venerable research institution.
Lydia Coutré writes for Crain’s Cleveland Business that Cleveland Clinic is driving exciting progress with its funding efforts with the NIH. Crain’s reports that the following grants have come through:
$3.1 million grant from National Institute of Child Health and Human Development to testing a combination of novel therapies’ ability to restore arm and hand function in patients who suffer from upper limb paralysis following a stroke.
$3 million grant to conduct a multisite clinical trial to study the long-term effects of aerobic exercise on slowing the progression of Parkinson’s disease. Jay Alberts is leading this effort.
$2.1 million NIH grant for new glioblastoma treatment strategies led by Justin Lathia. The grant has a five-year term.
$3.2 million grant for Dr. Emina Huang and Oliver Wessley for a five-year research project that seeks fundamental knowledge regarding “how inflammatory microenvironmental fibroblasts promote oncogenesis through miR20a and c-Myc. Understanding the pathogenesis of colitis-associated cancer will result in preventive strategies for this disease and other inflammation-associated malignancies.”
$2.2 million to Qing Wang’s four-year research from the National Heart, Lung and Blood Institute for studies that aim to identify a novel gene and molecular determinant (AGGF1) and a new signaling pathway for the development of pulmonary arterial hypertension (PAH), which remains a fatal disease.